Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Actimmune for Autosomal Dominant Osteopetrosis Type 2
NCT02584608Phase 2Completed
- Sponsor
- Indiana University
- Start
- Jan 2016
- Primary completion
- Nov 2019
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 2 trial of interferon gamma-1b in Autosomal Dominant Osteopetrosis Type 2, sponsored by Indiana University. Started Jan 2016; status: completed.
02
Drugs
interferon gamma-1b
03
Conditions
Autosomal Dominant Osteopetrosis Type 2
Beyond the preview
Go deeper on NCT02584608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02584608.